Primobolan 200 by Dragon Pharma

Dragon Pharma Original Formula

Methenolone Enanthate

Primobolan 200200 mg/ml
Ester Enanthate
Half-Life ~10 days
Anabolic Ratio 88
Androgenic Ratio 57
Carrier MCT Oil
Form Injection, 10ml
Availability: Out of stock
Wishlist

Methenolone Enanthate — Primobolan 200 by Dragon Pharma

Primobolan 200 is Dragon Pharma's high-concentration formulation of Methenolone Enanthate at 200mg/ml — the same active compound as Primobolan 100 at twice the concentration per ml. For full scientific background on Methenolone's properties — including why it doesn't aromatise, its unique oral bioavailability, its reduced HPG suppression profile and its history — see the Primobolan 100 page. This page focuses on the practical case for the 200mg/ml formulation.

Also searched as: Methenolone Enanthate 200mg, Primobolan 200, Primo 200 Dragon Pharma, high-concentration Primobolan.

Why 200mg/ml — The Dose Economics Argument

Primobolan's modest anabolic ratio (88) means effective performance doses start at 400mg/week and often extend to 600-1000mg/week in experienced users. The concentration difference between 100mg/ml and 200mg/ml becomes operationally significant at these doses:

Weekly Dose Primobolan 100 (volume) Primobolan 200 (volume) Injections per week (2x/week split)
400 mg/week 4 ml/week 2 ml/week 2ml vs 1ml per injection
600 mg/week 6 ml/week 3 ml/week 3ml vs 1.5ml per injection
800 mg/week 8 ml/week 4 ml/week 4ml vs 2ml per injection

At 600mg/week with Primobolan 100, each twice-weekly injection is 3ml — a volume that is uncomfortable and impractical for a single injection site. With Primobolan 200, the same 600mg/week requires only 1.5ml per injection — a manageable single-site volume. For users running Primobolan at 600mg/week or above, the 200mg/ml formulation is practically essential.

The High-Dose Primobolan Rationale

Why do experienced users run Primo at 600-1000mg/week when the anabolic ratio is only 88?

  • Methenolone's anabolic ratio understates its practical effect at the receptor level in certain tissue — in-vitro assays on which ratios are based don't fully capture in-vivo tissue-specific activity
  • At high doses, Primobolan's mild suppression advantage is lost to some degree — but the lack of aromatisation, minimal androgenic side effects and non-hepatotoxic profile remain intact regardless of dose
  • The combination of high Primobolan dose + moderate testosterone provides a unique stack: high total anabolic load from Primobolan's volume combined with testosterone's stronger AR binding for strength and androgenic function
  • The "more Primo, less testosterone" approach at higher total doses reduces estrogen burden (since Primobolan doesn't aromatise) while maintaining meaningful anabolic activity — particularly valuable in pre-competition lean mass phases

Effects and Benefits

  • Identical compound profile to Primobolan 100 — same Methenolone Enanthate properties
  • Twice the concentration — half the injection volume for equivalent weekly doses
  • Practical for doses above 400mg/week where 100mg/ml formulation creates uncomfortable injection volumes
  • Same no-aromatisation, mild suppression, lean mass quality profile

Dosage and Administration

Use Case Weekly Dose Volume at 200mg/ml Frequency
Standard performance 400–600 mg/week 2–3 ml/week Twice weekly (1–1.5ml per injection)
High-dose protocol 600–1,000 mg/week 3–5 ml/week Twice weekly (1.5–2.5ml per injection)

Building a Cycle Around Primobolan 200

  • Enantat 250 at 250-500mg/week as testosterone base — matched long-ester, same twice-weekly injection day
  • Masteron 200 for a fully non-aromatising lean mass trio: Primo 200 + Masteron 200 + Test E for maximum quality mass with minimum estrogen burden
  • Clomid or Nolvadex for PCT — lighter PCT than after more suppressive compounds

"Primobolan 200 is the practical formulation for users running 600mg/week or above — halving injection volume from the 100mg/ml version makes high-dose Primobolan protocols viable without 3-4ml per injection site."

Storage and Handling

Store Primobolan 200 at room temperature away from direct sunlight and heat. Use sterile technique for every draw.

Please log in to write review.

The active compound is identical — same Methenolone Enanthate, same pharmacological properties, same effects. The only difference is concentration: 100mg/ml versus 200mg/ml. At equal weekly doses, Primobolan 200 requires exactly half the injection volume of Primobolan 100. The choice is entirely about practical injection volume at your intended weekly dose.

When your weekly Primobolan dose is 400mg or above. At 400mg/week with Primobolan 100, each twice-weekly injection is 2ml — workable. At 600mg/week with Primobolan 100, each injection becomes 3ml — uncomfortable for a single site. The same 600mg/week with Primobolan 200 requires only 1.5ml per injection — a practical single-site volume. For protocols at 600mg/week and above, Primobolan 200 is the more practical formulation.

Primobolan's modest anabolic ratio (88) means it must be dosed in higher volume to generate meaningful anabolic load. At high doses its advantages — no aromatisation, minimal androgenic side effects, non-hepatotoxic profile — all remain intact, while total anabolic effect scales with dose. The "high Primo, moderate testosterone" approach at 600-1000mg/week Primobolan with 250-400mg/week testosterone creates a high total anabolic load with significantly less estrogen burden than equivalent testosterone-dominant stacks — particularly valuable in pre-competition lean mass phases.

At 400mg/week (twice-weekly): 1ml per injection. At 600mg/week: 1.5ml per injection. At 800mg/week: 2ml per injection. At 1000mg/week: 2.5ml per injection. All of these are comfortable single-site injection volumes — which is precisely the practical advantage of the 200mg/ml concentration over 100mg/ml at these performance doses.

Yes — this is one of the most effective non-aromatising lean mass combinations available. Primobolan 200 contributes anabolic mass quality and mild HPG preservation; Masteron 200 adds muscle hardness, internal aromatase inhibition (reducing estrogen from the testosterone component) and SHBG binding increasing free testosterone. Adding Testosterone Enanthate as the base creates a three-compound all-enanthate stack where all compounds are on the same twice-weekly injection schedule with minimal estrogen management demands.

No — concentration affects injection volume only, not pharmacological activity. The same weekly dose of Methenolone Enanthate produces identical blood levels and identical side effect profiles regardless of whether it came from the 100mg/ml or 200mg/ml formulation. Side effects scale with total weekly dose of the active compound, not with the concentration of the vial it was drawn from.